SC 13D

Company

Milestone Pharmaceuticals Inc.

Filed

May 14, 2019

Accession Number

0001193125-19-146584

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →